| IHD with BMCs-Tx(n=12) | IHD without BMCs-Tx(n=12) | P |
---|---|---|---|
Age | 62 ± 6 | 60 ± 5 | NS |
m/f | 8/4 | 9/3 | NS |
Cardiovascular Risk Factors (%) | Â | Â | Â |
Hypertension | 70 | 65 | NS |
Hyperlipidemia | 60 | 60 | NS |
Smoking | 80 | 75 | NS |
Diabetes | 30 | 30 | NS |
Positive family history of CAD | 20 | 15 | NS |
Transmural myocardial infarction, months before Tx | 20 ± 8 | 24 ± 8 | NS |
No. of diseased vessels | 2 ± 0.8 | 2 ± 0.8 | NS |
Infarct-related vessel (LAD/LCX/RCA) | 10/0/2 | 9/0/3 | NS |
Time from symptom onset to first reperfusion therapy (hr) | 6 ± 5 | 6 ± 4 | NS |
Primary reperfusion therapy (%) | 100 | 100 | NS |
PTCA/Stent at the time of AMI | 12/12 | 12/12 | NS |
Medication (%) | Â | Â | Â |
Aspirin | 100 | 100 | NS |
Clopidogrel | 100 | 100 | NS |
ACE inhibitor or AT II blocker | 100 | 100 | NS |
Beta-blocker | 100 | 100 | NS |
Aldosterone Antagonist | 25 | 25 | NS |
Statin | 100 | 100 | NS |
Laboratory parameters | Â | Â | Â |
CPK U/L | 2010 ± 540 | 2145 ± 670 | NS |